(MUSIC) AS I MENTIONED AT THE TOP OF THE SHOW, WE
ARE RE-AIRING AN INFORMATIVE TELL NOMINATED SEGMENT.
IN FACT, THIS IS A TELLY.
AND IT'S GIVEN TO THE BEST OF THE BEST IN THE CABLE TV INDUSTRY AND WE'RE REALLY VERY
HONORED HERE BECAUSE WE HERE AT O2 HAVE BEEN AWARDED A TELLY MANY MANY TIMES BEFORE SO
PLEASE WATCH THIS VERY SPECIAL SEGMENT.
(MUSIC) LIVER CANCER.
IT AFFECTS 1 IN EVERY 35,000 PEOPLE EACH YEAR.
KNOWN AS HEPATOCELLULAR CARCINOMA OR HCC.
IT PLAGUES MEN SLIGHTLY MORE THAN WOMEN BUT REMAINS A DISEASE
OUR NEXT GUEST IS DETERMINED TO HELP CONQUER.
JOINING US TO TALK ABOUT NOVEL OUTPATIENT TREATMENTS AGAINST
LIVE CANCER IS DR.
MAUREEN KOHI AN INTERVENTIONAL RADIOLOGIST AT
THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO.
DOCTOR, WELCOME.
IT'S SO GREAT TO HAVE YOU BACK IN THE STUDIO WITH US.
THANK YOU.
YOU KNOW, WHAT DO TYPICAL HCC RISK FACTORS TELL US ABOUT THE
CHANCES OF BEING DIAGNOSED WITH LIVER CANCER?
SO, THE MOST COMMON RISK FACTORS INCLUDE VIRAL HEPATITIS.
OKAY.
SO, HEPATITIS B AND C. SO, IF YOU KNOW YOU HAVE THAT OR
A LOVED ONE HAS THAT THEN YOU CAN HAVE A HIGHER CHANCE OF
BEING DETECTED AND YOU CAN GET SCREENING FOR LIVER CANCER.
OBESITY, TYPE 2 DIABETES, ALCOHOL CONSUMPTION.
THOSE ARE ALSO RISK FACTORS.
SO, IF YOU ARE AWARE OF THAT, AND IF YOUR DOCTOR IS AWARE OF
THOSE RISK FACTORS THE DIAGNOSIS CAN BE EXPEDITED AS WELL.
FROM A TREATMENT PERSPECTIVE IN TERMS OF HOPE AND HELP.
WHAT'S HAPPENING NOW FOR THOSE BEING DIAGNOSED WITH HCC?
SO THE CURATIVE THERAPIES FOR HCC INCLUDE LIVER
TRANSPLANTATION AND ALSO SURGICAL REMOVAL OF THE TUMOR.
THE PROBLEM IS, THAT NOT EVERYONE DIAGNOSED WITH HCC
QUALIFIES FOR A TRANSPLANT OR SURGERY.
SO, WHEN GREAT NOVEL TECHNOLOGY IS A LIVER DIRECTED THERAPY WITH
RADIOEMBOLIZATION SUCH AS THERASPHERE.
AND THIS IS A LIVER DIRECTED THERAPY WHERE WE INJECT THESE
SMALL BEADS THAT ARE COATED WITH RADIOACTIVE MATERIAL INTO THE
TUMOR.
AND THAT CAUSES THE DEATH OF THE CANCER CELLS.
AND SO THE TUMOR GETS SMALLER.
SO, THE PATIENTS HAVE MORE TIME TO GET A LIVER TRANSPLANT OR THE
TUMOR GETS SO SMALL THAT THE SURGEON CAN FINALLY TAKE THE
PATIENT TO THE OPERATING ROOM AND REMOVE THE TUMOR.
AND IT WILL ENHANCE THEIR SURVIVAL.
WELL, THAT'S GREAT NEWS.
REALLY.
YES.
AND WHAT MAKES THIS TREATMENT PREFERABLE?
I MEAN I THINK I KNOW, BUT SAY THAT FOR ME AGAIN.
SO, I THINK THE BEST PART ABOUT THIS TREATMENT IS THAT IT'S AN
OUT PATIENT PROCEDURE.
SO, YOU GO IN TO THE HOSPITAL.
YOU GET THE PROCEDURE AFTER A BRIEF RECOVERY, YOU GO HOME.
THE QUALITY OF LIFE IS MAINTAINED SO YOU STILL GET TO
WAKE UP AT YOUR HOUSE AND RUN YOUR ERRANDS.
AND THE HOPE OF GETTING ADDITIONAL THERAPY AFTERWARDS.
SO IF YOU NEED ADDITIONAL LOCAL REGIONAL THERAPY TO THE LIVER.
IF YOU NEED SURGERY TO THE LIVER, IT'S STILL AVAILABLE TO
YOU.
THAT IS SO GREAT.
AND WHAT ARE THE CRITERIA FOR SUCCESSFUL TREATMENT?
USUALLY HAPPENS AFTER THE PROCEDURE, ABOUT ONE MONTH TO
THREE MONTHS LATER, PATIENTS UNDERGO SOME SORT OF IMAGING.
EITHER A CAT-SCAN OR AN MRI.
AND WHAT WE HOPE TO SEE IS THE TUMOR HAS SHRUNK SIGNIFICANTLY.
AND ALSO IT HAS DIED SO THAT THE PATIENTS CAN EITHER GO ON TO
HAVE OTHER CURATIVE THERAPIES SUCH AS LIVER TRANSPLANTATION OR
SURGICAL RESECTION.
WHAT'S THE MOST TAKEAWAY INFORMATION WE CAN GET?
YES, I THINK IS YOU HAVE HCC OR IF A LOVED ONE HAS HCC, IT'S
IMPORTANT TO KNOW THAT THERE ARE A LOT OF DIFFERENT THERAPIES OUT
THERE AND NOVEL THERAPIES OUT THERE SUCH AS THERASPHERE AND
RADIOEMBOLIZATION SO IT'S REALLY IMPORTANT TO TALK TO YOUR
DOCTOR.
ASK THEM IF YOU QUALIFY OR IF YOU CAN TALK TO SOMEBODY THAT
KNOWS MORE ABOUT IT.
SUCH GREAT INFORMATION!
THANK YOU SO MUCH FOR JOINING US TODAY.
AND IF YOU'D LIKE ADDITIONAL INFORMATION ON THIS IMPORTANT
MEDICAL AND HEALTH TOPIC, PLEASE VISIT US AT
THEBALANCINGACT.COM OR LOG ON TO
FACEBOOK/THEBALANCINGACTSFANS THERASPHERE IMPORTANT SAFETY
INFORMATION.
INDICATION.
THERASPHERE IS AUTHORIZED BY FEDERAL LAW FOR USE AS A
HUMANITARIAN DEVICE IN RADIATION TREATMENT OR AS A NEOADJUVANT TO
SURGERY OR TRANSPLANTATION IN PATIENTS WITH UNRESECTABLE HCC
WHO CAN HAVE PLACEMENT OF APPROPRIATELY POSITIONED HEPATIC
ARTERIAL CATHETERS.
THE DEVICE IS ALSO INDICATED FOR HCC PATIENTS WITH PARTIAL OR
BRANCH PORTAL VEIN THROMBOSIS OR OCCLUSION.
WHEN CLINICAL EVALUATION WARRANTS
THE TREATMENT.
THE EFFECTIVENESS OF THIS DEVICE FOR THIS USE HAS NOT BEEN
DEMONSTRATED.
ADVERSE REACTIONS.
THERASPHERE TREATMENT HAS SOME COMMON SIDE
EFFECTS INCLUDING MILD TO MODERATE FATIGUE, PAIN, AND
NAUSEA.
AND MAY OCCUR THROUGH OUT THE FIRST WEEK AFTER TREATMENT.
SOME PATIENTS MAY EXPERIENCE LOSS OF APPETITE AND TEMPORARY
CHANGES IN LIVER BLOOD TESTS.
THE INTRODUCTION OF MICROSPHERES INTO THE VASCULATURE OF THE
STOMACH OR OTHER ORGANS OF THE GASTROINTESTINAL TRACT MAY CAUSE
CHRONIC PAIN, ULCERATION, AND BLEEDING.
MICROSPHERE SHUNTING TO THE LUNGS MAY CAUSE EDEMA AND
FIBROSIS THAT MAY NOT BE REVERSIBLE.
FOR MORE DETAILS ON RARE OF SEVERE SIDE EFFECTS PLEASE REFER
TO THE THERASPHERE PACKAGE INSERT AT
WWW.THERASPHERE.COM FOR MORE INFORMATION PLEASE
REFER TO THE PACKAGE INSERT FOR THERASPHERE CONTRAINDICATIONS.
(MUSIC)